The key to controlling the spread of the
coronavirus disease 2019 (COVID-19) and reducing mortality is highly dependent on the safe and effective use of
vaccines for the general population. Current
COVID-19 vaccination practices (
intramuscular injection of
solution-based
vaccines) are limited by heavy reliance on medical professionals, poor compliance, and laborious vaccination recording procedures, resulting in a waste of health resources and low vaccination coverage, etc. In this study, we developed a smart mushroom-inspired imprintable and lightly detachable (MILD) microneedle platform for the effective and convenient delivery of multidose
COVID-19 vaccines and decentralized
vaccine information storage. The mushroom-like structure allows the MILD system to be easily pressed into the skin and detached from the patch base, acting as a "
tattoo" to record the
vaccine counts in situ without any storage equipment, offering quick accessibility and effortless readout, saving a great deal of valuable time and energy for both patients and health professionals. After loading inactivated SARS-CoV-2 virus-based
vaccines, MILD system induced a high level of
antibodies against the SARS-CoV-2 receptor-binding domain (RBD) in vivo without eliciting systemic toxicity and local damage. Collectively, this smart delivery platform serves as a promising carrier to improve
COVID-19 vaccination efficacy through its dual capabilities of
vaccine delivery and in situ data storage, thus exhibiting great potential for helping to contain the
COVID-19 pandemic or a resurgence.